The effect of the COVID-19 pandemic on US Food and Drug Administration funded clinical trials and natural history studies for rare diseases
Description
CONCLUSIONS: This study suggested two important lessons learned. First, virtual capabilities, when appropriate, can be an important component of trials because they decrease the travel burden on participants and reduce in-person risks, which should
